These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 24835321)

  • 21. Utilization of radial artery access for percutaneous coronary intervention for ST-segment elevation myocardial infarction in New York.
    Hannan EL; Farrell LS; Walford G; Berger PB; Stamato NJ; Venditti FJ; Jacobs AK; Holmes DR; Sharma S; King SB
    JACC Cardiovasc Interv; 2014 Mar; 7(3):276-83. PubMed ID: 24529933
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does the site of bleeding matter? A stratified analysis on location of TIMI-graded bleedings and their impact on 12-month outcome in patients with ST-segment elevation myocardial infarction.
    Vranckx P; Campo G; Anselmi M; Bolognese L; Colangelo S; Biondi-Zoccai G; Moreno R; Piva T; Favero L; Prati F; Nazzaro M; Díaz Fernández JF; Ferrari R; Valgimigli M;
    EuroIntervention; 2012 May; 8(1):71-8. PubMed ID: 22311867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of diabetes mellitus on clinical outcomes following primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.
    Jensen LO; Maeng M; Thayssen P; Tilsted HH; Terkelsen CJ; Kaltoft A; Lassen JF; Hansen KN; Ravkilde J; Christiansen EH; Madsen M; Sørensen HT; Thuesen L
    Am J Cardiol; 2012 Mar; 109(5):629-35. PubMed ID: 22152969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic implications of creatine kinase-MB measurements in ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention.
    Bagai A; Schulte PJ; Granger CB; Mahaffey KW; Christenson RH; Bell G; Lopes RD; Green CL; Lincoff AM; Armstrong PW; Roe MT
    Am Heart J; 2014 Oct; 168(4):503-511.e2. PubMed ID: 25262260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of baseline coronary occlusion and diabetes mellitus in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Piccolo R; Galasso G; Iversen AZ; Eitel I; Dominguez-Rodriguez A; Gu YL; de Smet BJ; Mahmoud KD; Abreu-Gonzalez P; Trimarco B; Thiele H; Piscione F
    Am J Cardiol; 2014 Oct; 114(8):1145-50. PubMed ID: 25193670
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of stress hyperglycemia on in-hospital stent thrombosis and prognosis in nondiabetic patients with ST-segment elevation myocardial infarction undergoing a primary percutaneous coronary intervention.
    Zhang JW; Zhou YJ; Cao SJ; Yang Q; Yang SW; Nie B
    Coron Artery Dis; 2013 Aug; 24(5):352-6. PubMed ID: 23835666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term prognostic value of mitral regurgitation in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention.
    López-Pérez M; Estévez-Loureiro R; López-Sainz A; Couto-Mallón D; Soler-Martin MR; Bouzas-Mosquera A; Peteiro J; Barge-Caballero G; Prada-Delgado O; Barge-Caballero E; Salgado-Fernández J; Calviño-Santos R; Vázquez-Rodríguez JM; Piñón-Esteban P; Aldama-López G; Vázquez-González N; Castro-Beiras A
    Am J Cardiol; 2014 Mar; 113(6):907-12. PubMed ID: 24461770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential 1-year clinical outcomes for ST-segment elevation myocardial infarction related to stent thrombosis or saphenous vein graft thrombosis.
    Arzamendi D; Ly HQ; Tanguay JF; Armero S; Jilaihawi H; Gallo R; Ibrahim R; L'Allier P; Blondeau L; Gosselin G; Gregoire J; Doucet S
    Catheter Cardiovasc Interv; 2013 Aug; 82(2):193-200. PubMed ID: 21805615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stent thrombosis with second-generation drug-eluting stents compared with bare-metal stents: network meta-analysis of primary percutaneous coronary intervention trials in ST-segment–elevation myocardial infarction [corrected].
    Philip F; Agarwal S; Bunte MC; Goel SS; Tuzcu EM; Ellis S; Kapadia SR
    Circ Cardiovasc Interv; 2014 Feb; 7(1):49-61. PubMed ID: 24280964
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: 5 years follow-up from the randomized DEDICATION trial (Drug Elution and Distal Protection in Acute Myocardial Infarction).
    Holmvang L; Kelbæk H; Kaltoft A; Thuesen L; Lassen JF; Clemmensen P; Kløvgaard L; Engstrøm T; Bøtker HE; Saunamäki K; Krusell LR; Jørgensen E; Tilsted HH; Christiansen EH; Ravkilde J; Køber L; Kofoed KF; Terkelsen CJ; Helqvist S
    JACC Cardiovasc Interv; 2013 Jun; 6(6):548-53. PubMed ID: 23683734
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical outcomes and predictors of unprotected left main stem culprit lesions in patients with acute ST segment elevation myocardial infarction.
    Baek JY; Seo SM; Park HJ; Kim PJ; Park MW; Koh YS; Chang KY; Jeong MH; Park SJ; Seung KB
    Catheter Cardiovasc Interv; 2014 Jun; 83(7):E243-50. PubMed ID: 22105969
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-O blood groups can be a prognostic marker of in-hospital and long-term major adverse cardiovascular events in patients with ST elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Cetin MS; Ozcan Cetin EH; Aras D; Topaloglu S; Temizhan A; Kisacik HL; Aydogdu S
    Thromb Res; 2015 Sep; 136(3):599-605. PubMed ID: 26251078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic impact of periprocedural bleeding and myocardial infarction after percutaneous coronary intervention in unselected patients: results from the EVENT (evaluation of drug-eluting stents and ischemic events) registry.
    Lindsey JB; Marso SP; Pencina M; Stolker JM; Kennedy KF; Rihal C; Barsness G; Piana RN; Goldberg SL; Cutlip DE; Kleiman NS; Cohen DJ;
    JACC Cardiovasc Interv; 2009 Nov; 2(11):1074-82. PubMed ID: 19926047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between ST-segment recovery and clinical outcomes after primary percutaneous coronary intervention: the HORIZONS-AMI ECG substudy report.
    Farkouh ME; Reiffel J; Dressler O; Nikolsky E; Parise H; Cristea E; Baran DA; Dizon J; Merab JP; Lansky AJ; Mehran R; Stone GW
    Circ Cardiovasc Interv; 2013 Jun; 6(3):216-23. PubMed ID: 23652600
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk and timing of recurrent ischemic events among patients with stable ischemic heart disease, non-ST-segment elevation acute coronary syndrome, and ST-segment elevation myocardial infarction.
    Pilgrim T; Vranckx P; Valgimigli M; Stefanini GG; Piccolo R; Rat J; Rothenbühler M; Stortecky S; Räber L; Blöchlinger S; Hunziker L; Silber S; Jüni P; Serruys PW; Windecker S
    Am Heart J; 2016 May; 175():56-65. PubMed ID: 27179724
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surrogate and clinical outcomes following ischemic postconditioning during primary percutaneous coronary intervention of ST--segment elevation myocardial infarction: a meta-analysis of 15 randomized trials.
    Khalili H; Patel VG; Mayo HG; de Lemos JA; Brilakis ES; Banerjee S; Bavry AA; Bhatt DL; Kumbhani DJ
    Catheter Cardiovasc Interv; 2014 Nov; 84(6):978-86. PubMed ID: 24948465
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of incidence of bleeding and mortality of men versus women with ST-elevation myocardial infarction treated with fibrinolysis.
    Mehta RH; Stebbins AS; Lopes RD; Califf RM; Pieper KS; Armstrong PW; Van de Werf F; Hochman JS; White HD; Topol EJ; Alexander JH; Granger CB
    Am J Cardiol; 2012 Feb; 109(3):320-6. PubMed ID: 22078221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic impact of staged versus "one-time" multivessel percutaneous intervention in acute myocardial infarction: analysis from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial.
    Kornowski R; Mehran R; Dangas G; Nikolsky E; Assali A; Claessen BE; Gersh BJ; Wong SC; Witzenbichler B; Guagliumi G; Dudek D; Fahy M; Lansky AJ; Stone GW;
    J Am Coll Cardiol; 2011 Aug; 58(7):704-11. PubMed ID: 21816305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relation between coronary calcium and major bleeding after percutaneous coronary intervention in acute coronary syndromes (from the Acute Catheterization and Urgent Intervention Triage Strategy and Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction Trials).
    Généreux P; Madhavan MV; Mintz GS; Maehara A; Kirtane AJ; Palmerini T; Tarigopula M; McAndrew T; Lansky AJ; Mehran R; Brener SJ; Stone GW
    Am J Cardiol; 2014 Mar; 113(6):930-5. PubMed ID: 24440325
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association among leukocyte count, mortality, and bleeding in patients with non-ST-segment elevation acute coronary syndromes (from the Acute Catheterization and Urgent Intervention Triage StrategY [ACUITY] trial).
    Palmerini T; Généreux P; Mehran R; Dangas G; Caixeta A; Riva DD; Mariani A; Xu K; Stone GW
    Am J Cardiol; 2013 May; 111(9):1237-45. PubMed ID: 23411106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.